Figure 14
Molecular docking results for key anti-inflammatory targets of EOYA, the active ingredient of Morchella esculenta (A): NR1I2; (B): PTGS2; (C): PTGS1; (D): CYP4F2; (E): CYP3A4).
Figure 14 | Scientific Reports
Molecular docking results for key anti-inflammatory targets of EOYA, the active ingredient of Morchella esculenta (A): NR1I2; (B): PTGS2; (C): PTGS1; (D): CYP4F2; (E): CYP3A4).
